AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CareGeographicals
Dose-Response Relationship, RadiationUltraviolet RaysNeoplasmsIncidenceCarcinogensCell Transformation, NeoplasticRisk FactorsAneuploidyRisk AssessmentEarly Detection of CancerBreast NeoplasmsRadiation DosageRegistriesRadiation, IonizingProstatic NeoplasmsLung NeoplasmsRadiation InjuriesStomach NeoplasmsNeoplasms, Radiation-InducedOvarian NeoplasmsColonic NeoplasmsUnited StatesRetrospective StudiesFollow-Up StudiesProspective StudiesSEER ProgramRiskRadiation ToleranceSurvival RateUterine Cervical NeoplasmsNeoplasm InvasivenessCohort StudiesSurvival AnalysisNeoplasm MetastasisPancreatic NeoplasmsColorectal NeoplasmsAge DistributionPrognosisRadiationMice, NudeAge FactorsGene Expression Regulation, NeoplasticCarcinoma, Squamous CellGenetic Predisposition to DiseaseCancer VaccinesNeoplasm StagingCarcinomaCombined Modality TherapySmokingRadiation ProtectionNeoplasm ProteinsUrinary Bladder NeoplasmsTime FactorsAntineoplastic AgentsJapanDisease ProgressionRadiation MonitoringAntineoplastic Combined Chemotherapy ProtocolsOdds RatioRadiotherapyOccupational ExposureSwedenOccupational DiseasesCell Line, TumorMutationNational Cancer Institute (U.S.)Receptors, EstrogenMammographyRectal NeoplasmsEuropean Continental Ancestry GroupCarcinoma, Non-Small-Cell LungEsophageal NeoplasmsTumor Markers, BiologicalAdenocarcinomaSurvivorsTreatment OutcomeSex DistributionPoisson DistributionDrug Resistance, NeoplasmProstate-Specific AntigenNeoplasm Recurrence, LocalConfidence IntervalsReverse Transcriptase Polymerase Chain ReactionEndometrial NeoplasmsMultivariate AnalysisXenograft Model Antitumor AssaysGene Expression ProfilingDisease-Free SurvivalRadiation OncologyQuestionnairesSkin NeoplasmsRNA, MessengerChinaNeoplasms, Second PrimaryLiver NeoplasmsAnticarcinogenic AgentsCell SurvivalNeoplasm TransplantationReceptor, erbB-2Iowa